ArticlePloS one2014

Aberrant upregulation of 14-3-3σ and EZH2 expression serves as an inferior prognostic biomarker for hepatocellular carcinoma.

Yi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.